Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
doi:10.1172/jci.insight.140532
Among AOM tirzepatide users who switched to a different GLP-1 medication between June and July, 82.8% (more than 8 out of 10) moved to AOM semaglutide
Tirzepatide delays gastric emptying, and Zepbound trials reported belching in 4% to 5% of dose groups versus 1% with placebo
Baseline b12 tests at 280 pg per milliliter, low-normal range
The company also helps its users learn if GLP-1 medications are covered by their insurance, so Ro takes on benefits verification and works with a partner to optimize prior authorizations, giving patients treatment options, coverage details, and cost estimates
US$ 23.25
US$ 23.37
US$ 26.48
